Previous Article | Next Article ![]()
Applied and Environmental Microbiology, August 2006, p. 5396-5402, Vol. 72, No. 8
0099-2240/06/$08.00+0 doi:10.1128/AEM.00298-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata 940-2118, Japan
Received 6 February 2006/ Accepted 2 June 2006
|
|
|---|
|
|
|---|
![]() View larger version (18K): [in a new window] |
FIG. 1. Components and functions of BDO and proposed pathway for aerobic degradation of biphenyl (A) and organization of the bph, etb, and ebd genes (B) in Rhodococcus sp. strain RHA1. (A) The proposed electron transfer reactions and the conversion of biphenyl to benzoate and 2-hydroxypenta-2,4-dienoate are indicated. The BDO consists of three components, including a terminal oxygenase complex of large and small subunits, a ferredoxin, and a ferredoxin reductase. The complex catalyzes the dihydroxylation of biphenyl and is preferentially involved in the determination of substrate specificity. Ferredoxin and ferredoxin reductase promote electron transfer from NADH to the large- and small-subunit complex. Compounds: I, biphenyl; II, cis-(2R,3S)-dihydroxy-1-phenylcyclohexa-4,6-diene (dihydrodiol); III, 2,3-dihydroxybiphenyl (2,3-DHBP); IV, 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate (meta-cleavage compound [HOPD]); V, benzoate; VI, 2-hydroxypenta-2,4-dienoate. Enzymes: BphB, dihydrodiol dehydrogenase; BphC, 2,3-DHBP 1,2-dioxygenase; BphD, HOPD hydrolase. (B) Arrows indicate ORFs. The filled arrows represent the ORFs encoding BDO subunits. The names of the genes are indicated below the arrows. The etbA4 gene is located 6.0 kb upstream from etbA1. The bphA1, ebdA1, and etbA1 genes encode the large subunit of BDO, the bphA2, ebdA2, and etbA2 genes encode the small subunit of BDO, bphA3 and ebdA3 encode the ferredoxin, and bphA4 and etbA4 encode the ferredoxin reductase. The plasmid location of each gene segment is indicated on the right. Abbreviations: B, BamHI; E, EcoRI; H, HindIII; M, MluI; P, PstI; S, StuI.
|
In this paper, we examine the involvement of the RHDO genes in the biphenyl/PCB degradation activity of RHA1. We constructed single- and double-disruption mutants of RHDO large-subunit genes and investigated the 4-chlorobiphenyl (4-CB) degradation activities of these mutants. In addition, we constructed insertion mutants of electron transfer component genes. Our results revealed that all of these genes are involved in biphenyl/PCB degradation activity in RHA1.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains and plasmids used in this study
|
2-D PAGE.
RHA1 was grown in 500 ml of 1/5 LB medium to an optical density at 600 nm (OD600) of approximately 1.5. The cells were harvested by centrifugation, washed twice with 5 ml of W minimal medium, and resuspended in W minimal medium to give an OD600 of 1.5. The cell suspension was incubated for 16 h with biphenyl at 30°C. The cells were then harvested by centrifugation, washed twice with 5 ml of 25 mM potassium phosphate buffer (pH 7.0), and resuspended in 10 ml of 25 mM potassium phosphate buffer (pH 7.0). They were disrupted by a single passage through a French press (SLM-Aminco, Rochester, NY) at an operating pressure of 20,000 lb/in2. Cell debris was removed by centrifugation (30,000 x g, 4°C, 15 min). The clear supernatant fluid was used for two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) as a protein sample. The concentration of protein in a sample was determined by means of a protein assay kit (Bio-Rad Laboratories, Hercules, Calif.), using bovine serum albumin as a standard. 2-D PAGE was carried out using a Mini-PROTEAN II 2-D cell (Bio-Rad Laboratories) according to the instructions of the manufacturer. Proteins (0.06 to 0.255 mg) were separated in the first dimension by isoelectric focusing on a pI gradient ranging from 4 to 7 and then further separated in the second dimension by sodium dodecyl sulfate-PAGE with a 12% polyacrylamide gel. After the second-dimension gel electrophoresis, the proteins were stained with a Coomassie brilliant blue R250 or silver stain kit (ATTO, Tokyo, Japan).
N-terminal amino acid sequencing.
The gel pieces containing target proteins were excised from the Coomassie brilliant blue-stained second-dimension gel and subjected to sodium dodecyl sulfate-PAGE analysis. After electrophoresis, the target proteins were blotted electrically onto a polyvinylidene difluoride membrane at 20 V for 1 h using a Trans-Blot SD cell (Bio-Rad). The part of the polyvinylidene difluoride membrane containing the target protein was excised and applied directly to a PPSQ-23 protein sequencer (Shimadzu, Kyoto, Japan).
Gene disruption.
The strategy for gene disruption in RHA1 was described previously (8). To construct single-insertion mutants, the 761-bp StuI-PvuII, 1,099-bp Eco52I, 330-bp AatII-NarI, and 731-bp MluI-SmaI fragments containing the internal segments of etbA1, bphA1, ebdA3, and etbA4, respectively, were inserted into pBlueKm, which is a pBluescript II SK(+) derivative harboring the aphII gene. The internal segment of bphA3 was amplified using the bphA3-F (5'-CCTCACAAAGATATGCAGCTCCGG-3') and bphA3-Rs (5'-CCTCTGCTGCAAGAGCACCTGGAGATC-3') primer pair and was inserted into pBlueKm. The resulting plasmids, pBKE2, pBAK1, pBKEA3, pBKA4-2, and pBKBA3, respectively, were introduced independently into RHA1 cells by electroporation. Transformants were selected on 1/3 LB agar plates containing 50 mg of kanamycin per liter and were subjected to Southern hybridization analysis in order to examine the insertion of pBKE2, pBAK1, pBKEA3, pBKA4-2, and pBKBA3 into etbA1, bphA1, ebdA3, etbA4, and bphA3, respectively, by single crossovers. Because ebdA1 is identical to etbA1, an ebdA1 insertion was selected along with an etbA1 insertion. In an insertion mutant, a pBlueKm segment is expected to be sandwiched between a pair of genes inactivated by terminal deletions.
To construct double-insertion mutants, the 761-bp StuI-PvuII and 330-bp AatII-NarI fragments containing the internal segments of etbA1 and ebdA3, respectively, were inserted into pBlueCm, which is a pBluescript II SK(+) derivative harboring the cmrA gene (3). The resulting plasmids, pBCEA1 and pBCEB3, respectively, were introduced independently into the cells of a single-insertion mutant by electroporation. Transformants were selected on 1/3 LB agar plates containing 50 mg of kanamycin and 15 mg of chloramphenicol per liter and were subjected to Southern hybridization analysis to examine the insertion of pBCEA1 and pBCEB3 into etbA1 or ebdA1 and ebdA3 by single crossover.
Resting cell assay.
RHA1 and its insertion mutants were grown on 1/5 LB medium at 30°C to give an OD600 of 0.2, and then the degradation genes were induced by incubation with vapor of ethylbenzene for another 16 h. Cells were collected by centrifugation, washed twice with 2 ml of W minimal medium, and resuspended in W minimal medium to give an OD600 of 1.0. One milliliter of cell suspension was preincubated for 5 min at 30°C and was incubated in a sealed 4.5-ml glass vial with shaking at 30°C after the addition of 50 nmol of 4-CB or 1 ppm each of PCB congeners. The cell suspensions of single- and double-disruption mutants were incubated for 60 and 120 min, respectively, with 4-CB and for 24 h with PCB congeners. Control cells were inactivated by being autoclaved at 121°C for 15 min prior to the addition of substrate. To stop the reaction, 0.1 ml of 6 N HCl was added to the mix, and 50 nmol of phenanthrene or 5 nmol of 4-chlorobiphenyl was added as an internal standard. After the addition of NaCl to saturation, 3 ml of ethyl acetate was added to the mixture, which was then mixed on a vortex mixer for 1 min. The supernatant was recovered, dehydrated with sodium sulfate, evaporated, and dissolved in 0.1 ml of ethyl acetate. One microliter of extract was analyzed by gas chromatography-mass spectrometry (GC-MS) (model 5971A; Agilent Technologies Co., Palo Alto, Calif.), using an Ultra-2 capillary column (50 m by 0.2 mm; Agilent Technologies Co.) as described previously (17).
|
|
|---|
To verify the protein products of etbA1 and ebdA1 in RHA1 induced during incubation with biphenyl, we performed 2-D PAGE (Fig. 2). The results for protein samples from the cells grown on biphenyl revealed the identity of a protein spot whose molecular mass and isoelectric point (pI) were 51 kDa and 5.5, respectively (Fig. 2B). These values were very close to those of 51.7 kDa and 5.2, respectively, which were estimated from the amino acid sequence of EtbA1/EbdA1. The N-terminal amino acid sequence of the protein from this spot was determined, and the obtained sequence, MLXSEXFSPG (X is an unknown), was correspondent with the sequence of EtbA1 and EbdA1 (MLRSERFSPG). These results indicated that either etbA1, ebdA1, or both are inducibly expressed as a protein product in RHA1 grown on biphenyl. In addition to EtbA1/EbdA1, 15 protein spots were unique to the cells grown on biphenyl in comparison to those grown in LB medium. One spot with a molecular mass of 34 kDa and a pI of 4.8 was assigned as the EtbC dioxygenase protein based on its deduced molecular mass, pI, and N-terminal amino acid sequence, AKVTELGYL. Another spot with a molecular mass of 45 kDa and a pI of 5.1 was estimated to be EtbA4, whose deduced molecular mass and pI are 44 kDa and 4.9, respectively (Fig. 2B).
![]() View larger version (32K): [in a new window] |
FIG. 2. Two-dimensional polyacrylamide gel electrophoresis analysis of soluble proteins from RHA1 cells before (A) and after (B) incubation in the presence of biphenyl for 16 h. Proteins were separated in an isoelectric point (pI) gradient from 4 to 7 and then in a 12% polyacrylamide gel, after which they were stained with Coomassie brilliant blue R250. The area of the pI gradient from 5.1 to 5.5 and of molecular mass from 30.0 to 66.0 kDa is shown. The pI and molecular mass scales are indicated at the top and left of each panel, respectively.
|
The degradation activity toward 4-CB of each insertion mutant was investigated by GC-MS. Autoclaved cells were used as a negative control. The degradation activities of HDB1 and HDA1 were diminished, and the reduction of 4-CB by either of these insertion mutants was half that by RHA1 after 30 min (Fig. 3A). The activity of HDT1 was only slightly lower than that of RHA1 (Fig. 3A). Taking into account the polar effect exerted on the activities of genes downstream from the inactivated gene, these results suggested that the etbA1, ebdA1, and bphA1 genes and/or the genes downstream from them are involved in biphenyl/PCB degradation.
![]() View larger version (27K): [in a new window] |
FIG. 3. 4-Chlorobiphenyl degradation activities of RHA1 and RHDO large-subunit mutants. The results for single-insertion mutants (A) and double-insertion mutants (B) are presented. The remaining amount of 4-chlorobiphenyl was determined by gas chromatography-mass spectrometry. The degradation activities of the derivatives harboring plasmids containing wild-type genes are also shown. Each value is the mean of triplicate independent experiments, with the standard deviation indicated by error bars. Symbols are explained to the right of the panels. Plasmids are indicated in parentheses, and the mutation genotype of a strain and the wild-type gene in a plasmid are indicated in square brackets.
|
Double disruption of three RHDO large-subunit genes.
Because the insertion mutants mentioned above did not provide sufficient evidence that RHDO terminal oxygenase component genes play a role in biphenyl/PCB degradation in RHA1, we performed double-disruption experiments. The double-insertion etbA1 bphA1 and ebdA1 bphA1 mutants were constructed by using the bphA1 mutant, HDA1, as the parent strain and were designated HDAT1 and HDAB1, respectively. The double-insertion etbA1 ebdA1 mutant, designated HDBT1, was constructed from the ebdA1 mutant, HDB1.
After examining the ability of the single-disruption mutants to degrade 4-CB, we investigated the 4-CB degradation activity of each double-insertion mutant. The degradation activity of HDAT1 was lower than that of its parent strain, HDA1, and was one-quarter that of RHA1 (Fig. 3B). This degradation activity was estimated to depend solely on the ebdA1A2-encoded terminal oxygenase component (EbdA1A2 component), suggesting that the EbdA1A2 component plays a part in biphenyl/PCB degradation in RHA1. Because HDAT1 was constructed with the etbA1 inactivation of HDA1, the reduction of degradation activity appears to have originated from the inactivation of etbA1. Thus, the terminal oxygenase component encoded by etbA1A2 (EtbA1A2 component) appears to play an important role in biphenyl/PCB degradation in RHA1. On the other hand, the 4-CB degradation activity of HDAB1 was approximately equal to that of the negative control, irrespective of the presence of intact etbA1A2 (Fig. 3B). For HDAB1, it was suggested that the expression of both bphA3 and ebdA3 was inhibited by the polar effect caused by the respective insertions into bphA1 and ebdA1, respectively. Because of the absence of the electron transfer component, the EtbA1A2 component, which is intact in HDAB1, appears to have lost its activity. This notion was supported by the introduction of plasmid pK4TEB3, containing ebdA3, into HDAB1. The degradation activity of HDAB1 was restored by the introduction of pK4TEB3 to a level approximately equal to that of HDAT1 (Fig. 3B). These results again indicated that the EtbA1A2 component is involved in biphenyl/PCB degradation in RHA1. For HDAB1, we conjectured that not only the bphA3 gene but also the adjacent bphA4 gene is inhibited by the polar effect. However, the introduction of the sole ebdA3 gene restored the activity of HDAB1. These results suggested that another ferredoxin reductase gene, probably etbA4, plays a role in biphenyl/PCB degradation.
The degradation activity of HDBT1 was estimated to depend solely on bphA1A2, which confirmed that the bphA1A2-encoded terminal oxygenase component is functional in biphenyl/PCB degradation in RHA1. HDBT1 exhibited almost the same activity as its parent strain, HDB1 (Fig. 3B), although intact etbA1A2 existed in HDB1. These results may suggest that the sole electron transfer components in HDB1 encoded by bphA3 and bphA4 are not sufficient to account for the obvious activity of the etbA1A2-encoded dioxygenase.
Disruption of two RHDO ferredoxin genes and a ferredoxin reductase gene.
As previously mentioned, ebdA3 and etbA4, which encode a ferredoxin and a ferredoxin reductase, respectively, are thought to be involved in biphenyl/PCB degradation in RHA1. To confirm this involvement, we disrupted these genes by the same method used for the disruption of the RHDO large subunits. The bphA3 gene was also disrupted by the same method. The ebdA3, etbA4, and bphA3 insertion mutants were designated HDB3, HDT4, and HDA3, respectively. We also made repeated attempts to construct a corresponding insertion mutant of bphA4, but these failed.
The ability of each insertion mutant to degrade 4-CB was investigated by GC-MS. The degradation activities of the ferredoxin gene mutants were diminished, with HDB3 and HDA3 realizing one-third and one-half of the 4-CB reduction achieved by RHA1, respectively (Fig. 4). To examine whether the reduction of 4-CB degradation activity was caused by the inactivated gene, a wild-type gene was inserted next to the bphA1 promoter in vector pK4tsr, which was introduced into the mutant to complement each mutation. Plasmid pK4TEB3, containing ebdA3, and pK4TBA3, containing bphA3, were independently introduced into HDB3 and HDA3, respectively, by electroporation. The 4-CB degradation activities of both HDB3 and HDA3 were restored by the introduction of either ebdA3 or bphA3 (Fig. 4A and B). These results indicated that both ferredoxin genes, bphA3 and ebdA3, are involved in biphenyl/PCB degradation. A double-insertion ebdA3 bphA3 mutant was also constructed by using HDA3 as the parent strain and was designated HDAB33. The 4-CB degradation activity of HDAB33 was approximately equal to that of the negative control (Fig. 4B), suggesting that EbdA3 and BphA3 are the only dominant ferredoxin components involved in biphenyl/PCB degradation in RHA1.
![]() View larger version (28K): [in a new window] |
FIG. 4. 4-Chlorobiphenyl degradation activities of mutant strains with insertion mutations in RHDO electron transfer components. The results for HDB3 (A), HDA3 (B), and HDT4 (C), with insertion mutations in ebdA3, bphA3, and etbA4, respectively, are presented. The remaining amount of 4-chlorobiphenyl was determined by gas chromatography-mass spectrometry. The degradation activities of the strains harboring plasmids for complementation are also shown. Each value is the mean of triplicate independent experiments, with the standard deviation indicated by error bars. Symbols are explained to the right of the panels. Plasmids are indicated in parentheses, and the mutation genotype of a strain and the wild-type gene in a plasmid are indicated in square brackets.
|
Transformation of PCB congeners by insertion mutants.
It is known that the large subunits of terminal oxygenase components are major determinants of the substrate preference of the RHDO. In consideration of the low sequence similarity between EtbA1A2/EbdA1A2 and BphA1A2, it was expected that the substrate preferences would differ between EtbA/EbdA and BphA dioxygenase species. Therefore, the substrate preferences of EtbA/EbdA and BphA for PCB congeners were investigated by using the insertion mutants. The bphA1 mutant, HDA1, and the etbA1 ebdA1 mutant, HDBT1, were employed as EtbA/EbdA- and BphA-expressing strains, respectively. A mixture of five ortho-substituted PCB congeners that consisted of 2,2'-, 2,3-, 2,5,2'-, 2,5,2',5'-, and 2,4,5,2',5'-chlorobiphenyl (solution A) and a mixture of five para-substituted PCB congeners that consisted of 4,4'-, 2,4,2',4'-, 2,4,3',4'-, 3,4,3',4'-, and 2,4,5,2',4',5'-chlorobiphenyl (solution B) were used as substrates. The results are shown in Fig. 5. Although the degradation activity of HDA1 was lower than that of RHA1, the substrate preference of EtbA/EbdA-expressing HDA1 was almost identical to that of RHA1. On the other hand, BphA-expressing HDBT1 showed extremely low degradation activities toward 2,4,2',4'-, 2,4,3',4'-, 2,5,2',5'-, and 2,4,5,2',5'-chlorobiphenyls. The results for HDBT1 were almost correspondent with those obtained by using Rhodococcus erythropolis IAM1399 expressing bphA1A2A3A4 (16). These results indicated that EtbA/EbdA and BphA have different substrate preferences for PCB congeners and suggested that EtbA/EbdA plays an important role in the degradation of highly chlorinated biphenyls. BphA appears to play a role in the degradation of PCBs to some extent, because HDBT1 showed good activities toward 2,2'-, 2,3-, and 2,5,2'-chlorobiphenyls in addition to 4-CB (Fig. 3 shows the data for 4-CB).
![]() View larger version (24K): [in a new window] |
FIG. 5. Degradation of PCB congeners by RHA1 (black bars), by the bphA1 mutant, HDA1 (gray bars), and by the etbA1 ebdA1 double knockout, HDBT1 (white bars). Solution A consisted of five mainly ortho-substituted PCB congeners, 2,2'-dichlorobiphenyl, 2,3-dichlorobiphenyl, 2,5,2'-trichlorobiphenyl, 2,5,2',5'-tetrachlorobiphenyl, and 2,4,5,2',5'-pentachlorobiphenyl. Solution B consisted of five mainly para-substituted PCB congeners, 4,4'-dichlorobiphenyl, 2,4,2',4'-tetrachlorobiphenyl, 2,4,3',4'-tetrachlorobiphenyl, 3,4,3',4'-tetrachlorobiphenyl, and 2,4,5,2',4',5'-hexachlorobiphenyl. Each value is the mean of triplicate independent experiments, with the standard deviation indicated by error bars.
|
This study was supported in part by a grant-in-aid for the study of hazardous chemicals from the Ministry of Agriculture, Forestry, and Fisheries of Japan (HC-05-2322-1).
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»